Janssen Vaccines & Prevention B.v.

This study tested a new universal influenza vaccine designed to protect against many flu strains. 170 healthy adults aged 18-45 received either the vaccine or a placebo. The main goal was to check safety and side effects, and to measure the immune response triggered by the vaccin…

This study tested an experimental vaccine to prevent serious lung infections caused by RSV in adults aged 60 and older. Over 25,000 participants received either the vaccine or a placebo. The goal was to see if the vaccine could reduce cases of RSV-related lower respiratory tract …